Cargando…
Immunotargeting of tumor subpopulations in melanoma patients: A paradigm shift in therapy approaches
Several melanoma cell subpopulations with tumor-initiating and/or tumor-maintaining properties exist that may contribute to chemoresistance and tumor recurrence after standard therapies. One of these subpopulations expresses a B-cell marker, CD20. In a small pilot trial, we showed that a subset of S...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Landes Bioscience
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518536/ https://www.ncbi.nlm.nih.gov/pubmed/23243627 http://dx.doi.org/10.4161/onci.21357 |